
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.360 | 2.770 | 0.410 |
Shares | 97.630 | 97.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.101 | 17.767 |
Price to Book | 3.612 | 3.789 |
Price to Sales | 5.374 | 5.057 |
Price to Cash Flow | 16.565 | 15.071 |
Dividend Yield | 0.831 | 0.531 |
5 Years Earnings Growth | 10.392 | 14.340 |
Number of long holdings: 51
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 10.03 | 424.99 | -1.07% | |
Alnylam | US02043Q1076 | 7.60 | 251.15 | -2.79% | |
AbbVie | US00287Y1091 | 5.98 | 184.60 | -0.53% | |
Gilead | US3755581036 | 5.46 | 96.91 | -1.27% | |
Neurocrine | US64125C1099 | 5.26 | 115.71 | -1.54% | |
Amgen | US0311621009 | 4.64 | 265.86 | -2.28% | |
Guardant Health | US40131M1099 | 4.02 | 41.72 | +0.10% | |
Royalty Pharma | GB00BMVP7Y09 | 3.22 | 33.15 | +0.15% | |
Roivant Sciences Ltd Ordinary Shares | - | 3.19 | - | - | |
Sandoz | CH1243598427 | 3.16 | 38.03 | +2.07% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.21B | 0.63 | -2.45 | 4.75 | ||
LU1300848345 | 6.21B | 0.70 | -2.16 | - | ||
LU1323611266 | 3.92B | -2.14 | 5.24 | - | ||
LU1520716801 | 3.92B | -4.20 | 5.96 | - | ||
LU0403295958 | 2.83B | 10.02 | -1.73 | 3.40 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review